Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 7178-7189

  Lee, Lian Ni ^a   Burke, Shannon ^a,b   Montoya, Maria ^a,c   Borrow, Persephone ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL LINE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DNA VIRUS INFECTION; DOWN REGULATION; FEMALE; IMMUNIZATION; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SENDAI VIRUS INFECTION; SPLEEN; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DNA VIRUS; GENE EXPRESSION REGULATION; IMMUNOLOGY; PLASMA CELL; RNA VIRUS; VIRUS MENINGITIS;

ANIMALS; DENDRITIC CELLS; DNA VIRUSES; GENE EXPRESSION REGULATION; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; PLASMA CELLS; RNA VIRUSES; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 67449119121     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802526     Document Type: Article

References (67)

1. Biron, C., and G. C. Sen. 2001. Interferons and Other Cytokines. In Fields Virology 4th edition. D. M. Knipe, and P. M. Howley, eds. Lippincott Willians and Wilkins, Philadelphia, pp. 321-346.
2. Muller, U., U. Steinhoff, L. Reis, S. Hemmi, J. Pavlovic, R. Zinkernagel, and M. Aquet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
3. van den Broek, M. F., U. Muller, S. Huang, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral defense in mice lacking both α/β and γ interferon receptors. J. Virol. 69: 4792-4796.
4. Moskophidis, D., M. Battegay, M. A. Bruendler, E. Laine, I. Gresser, and R. M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to α/β interferon and to γ interferon. J. Virol. 68: 1951-1955. (Pubitemid 24065765)
5. Steinhoff, U., U. Muller, A. Schertler, H. Hengartner, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral protection by vesicular stomatitis virus-specific antibodies in α/βinterferon receptor-deficient mice. J. Virol. 69: 2153-2158.
6. Ou, R., S. Zhou, L. Huang, and D. Moskophidis. 2001. Critical role for α/β and γ interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75: 8407-8423.
7. Haller, O., G. Kochs, and W. Friedemann. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344: 119-130.
8. Capobianchi, M. R., I. Abbate, G. Cappiello, and M. Solmone. 2003. HCV and interferon: viral strategies for evading innate defence mechanisms in the virushost battle. Cell Death Differ 10 (Suppl. 1): S22-S24.
9. Horvath, C. M. 2004. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur. J. Biochem. 271: 4621-4628.
10. Leib, D. A. 2002. Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr. Top. Microbiol. Immunol. 269: 171-185.
11. Schweizer, M., P. Matzener, G. Pfaffen, H. Stalder, and E. Peterhans. 2006. "Self " and "nonself " manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists α/β interferon without blocking antiviral activity against unrelated viruses replicating in its host cells. J. Virol. 80: 6926-6935.
12. Takeuchi, O., and S. Akira. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20: 17-22.
13. Marie, I., J. E. Durbin, and D. E. Levy. 1998. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17: 6660-6669. (Pubitemid 28521799)
14. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, F. Briere, and G. Trinchieri. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2: 1144-1150.
15. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837. (Pubitemid 29275623)
16. Ito, T., R. Amakawa, and S. Fukuhara. 2002. Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum. Immunol. 63: 1120-1125.
17. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
18. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
19. Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85-95.
20. Bertoletti, A., and A. J. Gehring. 2006. The immune response during hepatitis B virus infection. J. Gen. Virol. 87: 1439-1449.
21. von Sydow, M., A. Sonnerborg, H. Gaines, and O. Strannegard. 1991. Interferon-α and tumor necrosis factor-α in serum of patients in various stages of HIV-1 infection. AIDS Res. Hum. Retroviruses 7: 375-380.
22. Lang, T., and A. Mansell. 2007. The negative regulation of Toll-like receptor and associated pathways. Immunol. Cell. Biol. 85: 425-434.
23. Weber, F., G. Kochs, and O. Haller. 2004. Inverse interference: how viruses fight the interferon system. Viral Immunol. 17: 498-515. (Pubitemid 40054230)
24. Katze, M., Y. He, and M. J. Gale. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2: 675-687.
25. Merigan, T. C., M. B. Oldstone, and R. M. Welsh. 1977. Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 268: 67-68. (Pubitemid 8136635)
26. Malmgaard, L., T. P. Salazar-Mather, C. A. Lewis, and C. A. Biron. 2002. Promotion of α/β interferon induction during in vivo viral infection through α/β interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76: 4520-4525.
27. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
28. Havenar-Daughton, C., G. A. Kolumam, and K. Murali-Krishna. 2006. Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176: 3315-3319. (Pubitemid 43363977)
29. Nguyen, K. B., W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien, A. Morinobu, M. Gadina, J. J. O'Shea, and C. A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297: 2063-2066.
30. Louten, J., N. van Rooijen, and C. Biron. 2006. Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection. J. Immunol. 77: 3266-3272. (Pubitemid 44277846)
31. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Briere, G. Trinchieri, and C. A. Biron. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195: 517-528.
32. Montoya, M., M. J. Edwards, D. M. Reid, and P. Borrow. 2005. Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN. J. Immunol. 174: 1851-1861. (Pubitemid 40223924)
33. Jung, A., H. Kato, Y. Kumagai, H. Kumar, T. Kawai, O. Takeuchi, and S. Akira. 2008. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82: 196-206.
34. Borrow, P., and M. B. Oldstone. 1997. Lymphocytic choriomeningitis virus. In Viral Pathogenesis. N. Nathanson, ed. Lippincott-Raven Publishers, Philadelphia, pp. 593-627.
35. Bukowski, J. F., C. A. Biron, and R. M. Welsh. 1983. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J. Immunol. 131: 991-996.
36. Holtermann, O. A., and E. A. Havell. 1970. Reduced interferon response in mice congenitally infected with lymphocytic choriomeningitis virus. J. Gen. Virol. 9: 101-103.
37. Saron, M. F., Y. Riviere, A. G. Hovanessian, and J. C. Guillon. 1982. Chronic production of interferon in carrier mice congenitally infected with lymphocytic choriomeningitis virus. Virology 117: 253-256. (Pubitemid 12170206)
38. Dutko, F. J., and M. B. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64 (Pt 8): 1689-1698.
39. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160: 521-540.
40. Wagner, A. M., J. K. Loganbill, and D. M. Besselson. 2003. Detection of Sendai virus and pneumonia virus of mice by use of fluorogenic nucleas reverse transcriptase polymerase chain reaction Comp. Med. 53: 173-177.
41. Karaghiosoff, M., R. Steinborn, P. Kovarik, G. Kriegshauser, M. Baccarini, B. Donabauer, U. Reichart, T. Kolbe, C. Bogdan, T. Leanderson, D. Levy, et al. 2003. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat. Immunol. 4: 471-477.
42. Montoya, M., R. Dawes, D. M. Reid, L. N. Lee, J. Piercy, P. Borrow, E. Z. Tchilian, and P. C. Beverley. 2006. CD45 is required for type 1 IFN production by dendritic cells. Eur. J. Immunol. 36: 2150-2158.
43. Tovey, M., J. Begon-Lours, and I. Gresser. 1974. A method for large-scale preparation of potent interferon preparations. Proc. Soc. Exp. Biol. Med. 146: 809.
44. Vremec, D., M. Zorbas, R. Scollay, D. J. Saunders, C. F. Ardavin, L. Wu, and K. Shortman. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176: 47-58.
45. + T cells following an acute virus infection. Eur. J. Immunol. 33: 2736-2743.
46. Lutz, M. B., N. A. Kukutsch, M. Menges, S. Rossner, and G. Schuler. 2000. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur. J. Immunol. 30: 1048-1052.
47. Girolomoni, G., M. B. Lutz, S. Pastore, C. U. Assmann, A. Cavani, and P. Ricciardi-Castagnoli. 1995. Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin. Eur. J. Immunol. 25: 2163-2169.
48. Prakash, A., E. Smith, C. K. Lee, and D. E. Levy. 2005. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J. Biol. Chem. 280: 18651-18657.
49. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
50. Martinez-Sobrido, L., E. I. Zuniga, D. Rosario, A. Garcia-Sastre, and J. C. de la Torre. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80: 9192-9199.
51. + T cell response during cross-priming. J. Immunol. 176: 4682-4689.
52. Jacobson, S., R. M. Friedman, and C. J. Pfau. 1981. Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence. J. Gen. Virol. 57: 275-283.
53. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
54. Martinez-Sobrido, L., P. Giannakas, B. Cubitt, A. Garcia-Sastre, and J. C. de la Torre. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81: 12696-12703.
55. Zhou, S., E. A. Kurt-Jones, L. Mandell, A. Cerny, M. Chan, D. T. Golenbock, and R. W. Finberg. 2005. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35: 822-830.
56. Zuniga, E. I., D. B. McGavern, J. L. Pruneda-Paz, C. Teng, and M. B. Oldstone. 2004. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat. Immunol. 5: 1227-1234.
57. Bro-Jorgensen, K., and S. Knudtzon. 1977. Changes in hemopoiesis during the course of acute LCM virus infection in mice. Blood 49: 47-57. (Pubitemid 8019483)
58. Borrow, P., S. Hou, S. Gloster, M. Ashton, and L. Hyland. 2005. Virus infection-associated bone marrow B cell depletion and impairment of humoral immunity to heterologous infection mediated by TNF-α/LTα. Eur. J. Immunol. 35: 524-532.
59. Bro-Jorgensen, K. 1978. The interplay between lymphocytic choriomeningitis virus, immune function, and hemopoiesis in mice. Adv. Virus Res. 22: 327-369.
60. Binder, D., J. Fehr, H. Hengartner, and R. M. Zinkernagel. 1997. Virus-induced transient bone marrow aplasia: major role of interferon-α/ β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185: 517-530.
61. Hahm, B., M. J. Trifilo, E. I. Zuniga, and M. B. Oldstone. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22: 247-257.
62. Borrow, P., C. F. Evans, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69: 1059-1070.
63. Rothlin, C. V., S. Ghosh, E. I. Zuniga, M. B. Oldstone, and G. Lemke. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124-1136.
64. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-α β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
65. Le Bon, A., and D. F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14: 432-436.
66. Tishon, A., P. Borrow, C. Evans, and M. B. Oldstone. 1993. Virus-induced immunosuppression, 1: age at infection relates to a selective or generalized defect. Virology 195: 397-405.
67. Odermatt, B., M. Eppler, T. P. Leist, H. Hengartner, and R. Zinkernagel. 1991. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. USA 88: 8252-8256.